Literature DB >> 3930250

Dexamethasone suppression and multiple hormonal responses (TSH, prolactin and growth hormone) to TRH in some psychiatric disorders.

C M Banki, M Vojnik, M Arato, Z Papp, Z Kovacs.   

Abstract

Baseline and TRH-induced changes of thyroid stimulating hormone (TSH), prolactin (PRL), and growth hormone (GH) were measured in 15 healthy control subjects and 63 psychiatric inpatients with DSM-III diagnoses of major depression (n = 19), schizophrenic disorder (n = 20), alcohol dependence (n = 10), and adjustment disorder (n = 14); baseline and postdexamethasone cortisol (CS) were also determined 3-6 days after the TRH-challenge. All patients and controls were women of similar mean age, weight, height, and they were free from interfering illness or drugs. Baseline TSH and PRL were lower in depression, TRH-induced TSH and PRL responses were lower in the whole patient group, but most markedly in depression and alcohol dependence. Postdexamethasone CS was significantly higher in depression, schizophrenia and alcohol dependence. Basal GH did not differentiate the subgroups; TRH-induced pathological GH responses were sometimes found in the patient groups. The differences were most marked quantitatively in major depression: a multivariate analysis of variance showed that delta TSH, postdexamethasone CS and delta PRL were the most important variables in separating patients from controls. A discriminant function derived from these variables classified all controls and 18 of 19 depressed patients correctly; however, 25 of the 44 other patients were also classified with depression. It was confirmed that psychiatric patients show significantly more endocrine disturbances than controls, and this was seen not only in major depression but also in at least three other conditions. Further work is needed to identify other neuroendocrine patterns more specific to depressive disorder.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930250     DOI: 10.1007/bf00380966

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  28 in total

1.  Differentiating mania from schizophrenia by the TRH test.

Authors:  I Extein; A L Pottash; M S Gold; D M Martin
Journal:  Am J Psychiatry       Date:  1980-08       Impact factor: 18.112

2.  The TRH stimulation test in subtypes of unipolar depression.

Authors:  S D Targum; S M Byrnes; A C Sullivan
Journal:  J Affect Disord       Date:  1982-03       Impact factor: 4.839

3.  Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa.

Authors:  K Maeda; Y Kato; N Yamaguchi; K Chihara; S Ohgo
Journal:  Acta Endocrinol (Copenh)       Date:  1976-01

4.  Abnormal dexamethasone suppression test in normal females.

Authors:  T Hällström; S Samuelsson; J Balldin; J Wålinder; C Bengtsson; E Nyström; B Andersch; G Lindstedt; P A Lundberg
Journal:  Br J Psychiatry       Date:  1983-05       Impact factor: 9.319

5.  The dexamethasone suppression test for melancholia.

Authors:  B J Carroll
Journal:  Br J Psychiatry       Date:  1982-03       Impact factor: 9.319

6.  Compensatory pituitary-thyroid mechanisms in major depressive disorder.

Authors:  S D Targum; A C Sullivan; S M Byrnes
Journal:  Psychiatry Res       Date:  1982-02       Impact factor: 3.222

7.  Neuroendocrine interrelationships in major depressive disorder.

Authors:  S D Targum; A C Sullivan; S M Byrnes
Journal:  Am J Psychiatry       Date:  1982-03       Impact factor: 18.112

8.  Multiple hormonal responses to protirelin (TRH) in depressed patients.

Authors:  A Winokur; J D Amsterdam; J Oler; J Mendels; P J Snyder; S N Caroff; D J Brunswick
Journal:  Arch Gen Psychiatry       Date:  1983-05

9.  Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?

Authors:  M Berger; P Doerr; R Lund; T Bronisch; D von Zerssen
Journal:  Biol Psychiatry       Date:  1982-11       Impact factor: 13.382

10.  Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia.

Authors:  M Raskind; E Peskind; M F Rivard; R Veith; R Barnes
Journal:  Am J Psychiatry       Date:  1982-11       Impact factor: 18.112

View more
  2 in total

1.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

2.  Thyroid function in clinical subtypes of major depression: an exploratory study.

Authors:  Konstantinos N Fountoulakis; Apostolos Iacovides; Philippos Grammaticos; George St Kaprinis; Per Bech
Journal:  BMC Psychiatry       Date:  2004-03-15       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.